Search Results - "Markus, H Z"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation by Jansen, Kathrin U., Rosolowsky, Mark, Schultz, Loren D., Markus, Henry Z., Cook, James C., Donnelly, John J., Martinez, Douglas, Ellis, Ronald W., Shaw, Alan R.

    Published in Vaccine (1995)
    “…Papillomaviruses infect epithelia of the skin and mucous membranes and cause benign or malignant tumours in animals and in humans. The viruses are highly…”
    Get full text
    Journal Article
  2. 2

    Sequence conservation within the major capsid protein of human papillomavirus (HPV) type 18 and formation of HPV-18 virus-like particles in Saccharomyces cerevisiae by Hofmann, Kathryn J, Neeper, Michael P, Markus, Henry Z, Brown, Darron R, Muller, Martin, Jansen, Kathrin U

    Published in Journal of general virology (01-03-1996)
    “…1 Department of Virus and Cell Biology, Merck Research Laboratories, Sumneytown Pike, West Point, Pennsylvania 19486 2 Division of Infectious Diseases, Indiana…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Purification and characterization of human plasminogen activator inhibitor type I expressed in Saccharomyces cerevisiae by Gardell, S J, Hare, T R, Han, J H, Markus, H Z, Keech, B J, Carty, C E, Ellis, R W, Schultz, L D

    Published in Archives of biochemistry and biophysics (01-05-1990)
    “…The rapidly acting inhibitor of plasminogen activators, PAI-1, was produced intracellularly in Saccharomyces cerevisiae by using the ADH2 promoter to drive the…”
    Get more information
    Journal Article
  5. 5

    Factors affecting the secretion of staphylococcal enterotoxin A by Markus, Z.H, Silverman, G.J

    Published in Applied microbiology (01-09-1970)
    “…The biosynthesis of enterotoxin A by replicating and nonreplicating cells was investigated. Unlike enterotoxin B, a secondary metabolite, enterotoxin A…”
    Get full text
    Journal Article
  6. 6

    Vaccine against human hepatitis B virus prepared from antigen derived from human hepatoma cells in culture by McAleer, W J, Markus, H Z, Wampler, D E, Buynak, E B, Miller, W J, Weibel, R E, McLean, A A, Hilleman, M R

    “…Vaccine against human hepatitis B was prepared using antigen derived from hepatitis B carrier hepatoma cells grown in the interstices of a Diaflo hollow filter…”
    Get more information
    Journal Article
  7. 7

    Production of purified hepatitis B surface antigen from Alexander hepatoma cells grown in artificial capillary units by McAleer, W J, Markus, H Z, Bailey, F J, Herman, A C, Harder, B J, Wampler, D E, Miller, W J, Keller, P M, Buynak, E B, Hilleman, M R

    Published in Journal of virological methods (01-01-1983)
    “…An artificial capillary system was devised for growth of hepatoma cells that yields very high titers of hepatitis B surface antigen (HBsAg). High yield of…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Expression and purification of recombinant tick anticoagulant peptide (Y1W/D10R) double mutant secreted by Saccharomyces cerevisiae by Cook, J C, Schultz, L D, Huang, J, George, H A, Herber, W K, Ip, C, Joyce, J G, Mao, S S, Markus, H Z, Miller, W J, Sardana, M K, Lehman, E D

    Published in Protein expression and purification (01-08-1998)
    “…A double mutant of tick anticoagulant peptide (TAP) was cloned as a chimeric fusion with the yeast alpha-mating factor pre-proleader peptide. Expression in…”
    Get full text
    Journal Article
  10. 10

    Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae by Lehman, E D, Joyce, J G, Bailey, F J, Markus, H Z, Schultz, L D, Dunwiddie, C T, Jacobson, M A, Miller, W J

    Published in Protein expression and purification (01-06-1993)
    “…Hirudin (HIR), derived from leeches, and tick anticoagulant peptide (TAP) are polypeptide protease inhibitors of thrombin and coagulation factor Xa (fXa),…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Characterization of recombinant antistasin secreted by Saccharomyces cerevisiae by Przysiecki, C T, Joyce, J G, Keller, P M, Markus, H Z, Carty, C E, Hagopian, A, Sardana, M K, Dunwiddie, C T, Ellis, R W, Miller, W J

    Published in Protein expression and purification (01-06-1992)
    “…Secretion from recombinant yeast was used as a potential source of large quantities of the leech protein antistasin (ATS), a potent and highly specific…”
    Get more information
    Journal Article
  13. 13

    Human papillomavirus type II (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast by Lowe, Robert S, Brown, Darron R, Bryan, Janine T, Cook, James C

    Published in The Journal of infectious diseases (01-11-1997)
    “…It has been shown previously that immunization of animals with recombinant virus-like particles (VLPs) consisting of the viral capsid proteins L1 or L1 plus L2…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Stabilized Measles Vaccine in a Novel Single-Dose Delivery System: A Practical Reality for Worldwide Elimination of Measles by Hilleman, Maurice R., William J. Mc Aleer, Arlene A. Mc Lean, Eugene B. Buynak, Henry Z. Markus

    Published in Reviews of infectious diseases (01-05-1983)
    “…A live measles virus vaccine that is highly temperature-stable and dispensed in an inexpensive syringe is described. This configuration should prove useful for…”
    Get full text
    Journal Article
  16. 16

    Factors Affecting the Secretion of Staphylococcal Enterotoxin A by Markus, Z. H., Silverman, G. J.

    Published in Applied microbiology (01-09-1970)
    “…The biosynthesis of enterotoxin A by replicating and nonreplicating cells was investigated. Unlike enterotoxin B, a secondary metabolite, enterotoxin A…”
    Get full text
    Journal Article